<VariationArchive VariationID="224726" VariationName="NM_015100.4(POGZ):c.3456_3457del (p.Glu1154fs)" VariationType="Deletion" Accession="VCV000224726" Version="28" RecordType="classified" NumberOfSubmissions="14" NumberOfSubmitters="14" DateLastUpdated="2024-07-29" DateCreated="2016-03-26" MostRecentSubmission="2024-07-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="226509" VariationID="224726">
      <GeneList>
        <Gene Symbol="POGZ" FullName="pogo transposable element derived with ZNF domain" GeneID="23126" HGNC_ID="HGNC:18801" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q21.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="151402724" stop="151459494" display_start="151402724" display_stop="151459494" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="151375199" stop="151431940" display_start="151375199" display_stop="151431940" Strand="-" />
          </Location>
          <OMIM>614787</OMIM>
          <Haploinsufficiency last_evaluated="2017-12-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=POGZ">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2017-12-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=POGZ">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_015100.4(POGZ):c.3456_3457del (p.Glu1154fs)</Name>
      <CanonicalSPDI>NC_000001.11:151405577:CT:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1q21.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="151405578" stop="151405579" display_start="151405578" display_stop="151405579" variantLength="2" positionVCF="151405577" referenceAlleleVCF="CCT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="151378054" stop="151378055" display_start="151378054" display_stop="151378055" variantLength="2" positionVCF="151378053" referenceAlleleVCF="CCT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>E1145fs</ProteinChange>
      <ProteinChange>E1154fs</ProteinChange>
      <ProteinChange>E1059fs</ProteinChange>
      <ProteinChange>E1092fs</ProteinChange>
      <ProteinChange>E1101fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.151378054_151378055del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.151378054_151378055del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.151405578_151405579del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.151405578_151405579del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_046601.1" sequenceAccession="NG_046601" sequenceVersion="1" change="g.58887_58888del">
            <Expression>NG_046601.1:g.58887_58888del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001194937.2" sequenceAccession="NM_001194937" sequenceVersion="2" change="c.3429_3430del">
            <Expression>NM_001194937.2:c.3429_3430del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001181866.1" sequenceAccession="NP_001181866" sequenceVersion="1" change="p.Glu1145fs">
            <Expression>NP_001181866.1:p.Glu1145fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001194938.2" sequenceAccession="NM_001194938" sequenceVersion="2" change="c.3270_3271del">
            <Expression>NM_001194938.2:c.3270_3271del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001181867.1" sequenceAccession="NP_001181867" sequenceVersion="1" change="p.Glu1092fs">
            <Expression>NP_001181867.1:p.Glu1092fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015100.4" sequenceAccession="NM_015100" sequenceVersion="4" change="c.3456_3457del" MANESelect="true">
            <Expression>NM_015100.4:c.3456_3457del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_055915.2" sequenceAccession="NP_055915" sequenceVersion="2" change="p.Glu1154fs">
            <Expression>NP_055915.2:p.Glu1154fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_145796.4" sequenceAccession="NM_145796" sequenceVersion="4" change="c.3171_3172del">
            <Expression>NM_145796.4:c.3171_3172del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_665739.3" sequenceAccession="NP_665739" sequenceVersion="3" change="p.Glu1059fs">
            <Expression>NP_665739.3:p.Glu1059fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_207171.2" sequenceAccession="NM_207171" sequenceVersion="2" change="c.3297_3298del">
            <Expression>NM_207171.2:c.3297_3298del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_997054.1" sequenceAccession="NP_997054" sequenceVersion="1" change="p.Glu1101fs">
            <Expression>NP_997054.1:p.Glu1101fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA358732" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="614787.0010" DB="OMIM" />
        <XRef Type="rs" ID="869320764" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_015100.4(POGZ):c.3456_3457del (p.Glu1154fs) AND Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome" Accession="RCV000210322" Version="12">
        <ClassifiedConditionList TraitSetID="21504">
          <ClassifiedCondition DB="MedGen" ID="C4225351">Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-12-21" SubmissionCount="9">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_015100.4(POGZ):c.3456_3457del (p.Glu1154fs) AND not provided" Accession="RCV000822183" Version="16">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-11-01" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_015100.4(POGZ):c.3456_3457del (p.Glu1154fs) AND Neurodevelopmental disorder" Accession="RCV002277570" Version="1">
        <ClassifiedConditionList TraitSetID="37229">
          <ClassifiedCondition DB="MedGen" ID="C1535926">Neurodevelopmental disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-12-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_015100.4(POGZ):c.3456_3457del (p.Glu1154fs) AND Inborn genetic diseases" Accession="RCV002453755" Version="2">
        <ClassifiedConditionList TraitSetID="25797">
          <ClassifiedCondition DB="MedGen" ID="C0950123">Inborn genetic diseases</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-08-28" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-21" NumberOfSubmissions="14" NumberOfSubmitters="14" DateCreated="2016-03-26" MostRecentSubmission="2024-07-23">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">26942287</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31782611</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31981491</ID>
        </Citation>
        <DescriptionHistory Dated="2022-11-28">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="37229" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="38088" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Neurodevelopmental disorder</ElementValue>
                <XRef ID="MONDO:0700092" DB="MONDO" />
              </Name>
              <XRef ID="C1535926" DB="MedGen" />
              <XRef ID="D065886" DB="MeSH" />
              <XRef ID="MONDO:0700092" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="25797" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32761" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Inborn genetic diseases</ElementValue>
              </Name>
              <Citation Type="general" Abbrev="Langer et al., 2012">
                <ID Source="PubMed">22947299</ID>
              </Citation>
              <Citation Type="general" Abbrev="SACHDNC, 2013">
                <ID Source="PubMed">23037933</ID>
              </Citation>
              <Citation Type="general" Abbrev="EASAC/FEAM, 2013">
                <ID Source="PubMed">23169492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESHG/P3G/HUGO/PHGF, 2015">
                <ID Source="PubMed">25626707</ID>
              </Citation>
              <Citation Type="general" Abbrev="Alpha-1 Foundation, 2014">
                <ID Source="PubMed">24121147</ID>
              </Citation>
              <Citation Type="general" Abbrev="NBSTRN, 2015">
                <ID Source="PubMed">24394680</ID>
              </Citation>
              <Citation Type="general" Abbrev="EUNENBS, 2014">
                <ID Source="PubMed">23652378</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2014">
                <ID Source="PubMed">23881473</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/ACOG/NSGC/PQF/SMFM, 2015">
                <ID Source="PubMed">25730230</ID>
              </Citation>
              <Citation Type="general" Abbrev="Skirton et al., 2014">
                <ID Source="PubMed">24022298</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23619275</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2019">
                <ID Source="PubMed">31022120</ID>
              </Citation>
              <XRef ID="C0950123" DB="MedGen" />
              <XRef ID="D030342" DB="MeSH" />
            </Trait>
          </TraitSet>
          <TraitSet ID="21504" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33338" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome</ElementValue>
                <XRef ID="MONDO:0014606" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MRD37</ElementValue>
                <XRef Type="MIM" ID="616364" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">WHSUS</ElementValue>
                <XRef Type="MIM" ID="616364" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">White-Sutton syndrome is a neurodevelopmental disorder characterized by a wide spectrum of cognitive dysfunction, developmental delays (particularly in speech and language acquisition), hypotonia, autism spectrum disorder, and other behavioral problems. Additional features commonly reported include seizures, refractive errors and strabismus, hearing loss, sleep disturbance (particularly sleep apnea), feeding and gastrointestinal problems, mild genital abnormalities in males, and urinary tract involvement in both males and females.</Attribute>
                <XRef ID="NBK573972" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="13774" />
                <XRef ID="13774" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">34529370</ID>
                <ID Source="BookShelf">NBK573972</ID>
              </Citation>
              <XRef ID="468678" DB="Orphanet" />
              <XRef ID="C4225351" DB="MedGen" />
              <XRef ID="MONDO:0014606" DB="MONDO" />
              <XRef Type="MIM" ID="616364" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="498945" SubmissionDate="2022-03-29" DateLastUpdated="2022-04-02" DateCreated="2016-03-26">
        <ClinVarSubmissionID localKey="614787.0010_WHITE-SUTTON SYNDROME" title="POGZ, 1-BP DEL, NT3456_WHITE-SUTTON SYNDROME" />
        <ClinVarAccession Accession="SCV000266369" DateUpdated="2022-04-02" DateCreated="2016-03-26" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-29">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 2 unrelated patients with White-Sutton syndrome (WHSUS; 616364), Stessman et al. (2016) identified a de novo heterozygous 1-bp deletion in the POGZ gene, which the authors denoted as c.3456_3457del (c.3456_3457del, NM_015100.3), resulting in a frameshift and premature termination (Glu1154ThrfsTer4). Functional studies of the variant and studies of patient cells were not performed.</Attribute>
              <Citation>
                <ID Source="PubMed">26942287</ID>
              </Citation>
              <XRef DB="OMIM" ID="616364" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="POGZ" />
          </GeneList>
          <Name>POGZ, 1-BP DEL, NT3456</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, NT3456</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="614787.0010" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">WHITE-SUTTON SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3879258" SubmissionDate="2021-10-29" DateLastUpdated="2021-10-30" DateCreated="2021-10-30">
        <ClinVarSubmissionID localKey="PED9412.1|OMIM:616364" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001985057" DateUpdated="2021-10-30" DateCreated="2021-10-30" Type="SCV" Version="1" SubmitterName="Equipe Genetique des Anomalies du Developpement, Université de Bourgogne" OrgID="506039" OrganizationCategory="laboratory" OrgAbbreviation="GADteam" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-10-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="POGZ" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015100.2:c.3456_3457del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="616364" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10589804</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5014973" SubmissionDate="2022-08-22" DateLastUpdated="2022-08-29" DateCreated="2022-08-29">
        <ClinVarSubmissionID localKey="CLIN595|MONDO:700092" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002564452" DateUpdated="2022-08-29" DateCreated="2022-08-29" Type="SCV" Version="1" SubmitterName="Laboratory of Molecular Genetics (Pr. Bezieau's lab), CHU de Nantes" OrgID="505613" OrganizationCategory="laboratory" OrgAbbreviation="MedGenet" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-12-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="POGZ" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015100.3:c.3456_3457del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0700092" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11957132</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5030275" SubmissionDate="2022-09-04" DateLastUpdated="2022-09-17" DateCreated="2022-09-17">
        <ClinVarSubmissionID localKey="1-151378053-CCT-C" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002572657" DateUpdated="2022-09-17" DateCreated="2022-09-17" Type="SCV" Version="1" SubmitterName="3billion" OrgID="507830" OrganizationCategory="other" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">26942287</ID>
          </Citation>
          <Comment>The variant is not observed in the gnomAD v2.1.1 dataset. Frameshift variant is predicted to result in a loss or disruption of normal protein function through protein truncation. Multiple pathogenic variants are reported in the predicted truncated region. The variant has been reported at least twice as pathogenic with clinical assertions and evidence for the classification (ClinVar ID: VCV000224726 / PMID: 26942287). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Proband>yes</Proband>
            </Sample>
            <Method>
              <NamePlatform>NovaSeq</NamePlatform>
              <TypePlatform>whole exome sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002511" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="POGZ" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015100.4:c.3456_3457del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="616364" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12013725</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3877340" SubmissionDate="2021-10-25" DateLastUpdated="2022-10-01" DateCreated="2021-10-30">
        <ClinVarSubmissionID localKey="NM_015100.3:c.3456_3457del|OMIM:616364" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV001983391" DateUpdated="2022-10-01" DateCreated="2021-10-30" Type="SCV" Version="2" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation>
            <ID Source="PubMed">26942287</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31782611</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31981491</ID>
          </Citation>
          <Comment>Recurrent variant</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015100.3:c.3456_3457del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C4225351" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10565618</SubmissionName>
          <SubmissionName>SUB11808016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5043620" SubmissionDate="2022-10-06" DateLastUpdated="2022-10-15" DateCreated="2022-10-15">
        <ClinVarSubmissionID localKey="NM_015100.4:c.3456_3457del|OMIM:616364" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002579447" DateUpdated="2022-10-15" DateCreated="2022-10-15" Type="SCV" Version="1" SubmitterName="MGZ Medical Genetics Center" OrgID="255845" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-06-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="POGZ" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015100.4:c.3456_3457del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="616364" Type="MIM" />
          </Trait>
        </TraitSet>
        <Comment>ACMG criteria applied: PVS1_STR, PS2, PS4_MOD, PM2_SUP</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB12035528</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5464631" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_015100.4:c.3456_3457del|OMIM:616364" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002808068" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015100.4:c.3456_3457del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="616364" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2305913" SubmissionDate="2022-04-20" DateLastUpdated="2023-03-04" DateCreated="2020-03-14">
        <ClinVarSubmissionID localKey="GDXSV:224968" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV001167920" DateUpdated="2023-03-04" DateCreated="2020-03-14" Type="SCV" Version="3" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-04-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation, as the last 257 amino acids are replaced with 3 different amino acids, and other loss-of-function variants have been reported downstream in HGMD; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 26942287, 31981491, 31452935, 34215294, 31136090, 31782611)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="POGZ" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:1588423</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015100.3:c.3456_3457del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_101_20220420054204</SubmissionName>
          <SubmissionName>SUB6425168</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7576283" SubmissionDate="2023-10-18" DateLastUpdated="2023-10-28" DateCreated="2023-10-28">
        <ClinVarSubmissionID localKey="NM_015100.4:c.3456_3457del|OMIM:616364" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004049780" DateUpdated="2023-10-28" DateCreated="2023-10-28" Type="SCV" Version="1" SubmitterName="Genome-Nilou Lab" OrgID="507598" OrganizationCategory="laboratory" OrgAbbreviation="Genome Nilou" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>no</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="POGZ" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015100.4:c.3456_3457del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="616364" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13910671</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7909097" SubmissionDate="2024-01-25" DateLastUpdated="2024-02-04" DateCreated="2024-02-04">
        <ClinVarSubmissionID localKey="1:151405578" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV004232711" DateUpdated="2024-02-04" DateCreated="2024-02-04" Type="SCV" Version="1" SubmitterName="HudsonAlpha Institute for Biotechnology, HudsonAlpha Institute for Biotechnology" OrgID="505530" OrganizationCategory="laboratory" OrgAbbreviation="HA" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SampleLocalID">5111UCC</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000717" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001263" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001344" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="POGZ" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015100.4:c.3456_3457del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="616364" Type="MIM" />
          </Trait>
        </TraitSet>
        <StudyName>UCC-HudsonAlpha</StudyName>
        <StudyDescription>Utility of Genomic Sequencing in Community Care Contexts</StudyDescription>
        <SubmissionNameList>
          <SubmissionName>SUB14173579</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1857344" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2019-08-14">
        <ClinVarSubmissionID localKey="4547185|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000962974" DateUpdated="2024-02-14" DateCreated="2019-08-14" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-07-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">26942287</ID>
          </Citation>
          <Comment>This variant is not present in population databases (ExAC no frequency). For these reasons, this variant has been classified as Pathogenic. This variant has been observed to be de novo in individuals affected with POGZ-related conditions (PMID: 26942287). ClinVar contains an entry for this variant (Variation ID: 224726). This sequence change results in a premature translational stop signal in the POGZ gene (p.Glu1154Thrfs*4). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last¬†257¬†amino acids of the POGZ protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="POGZ" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.151378054_151378055del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB5371970</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5099976" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2022-11-29">
        <ClinVarSubmissionID localKey="a574715|MedGen:C0950123" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002616772" DateUpdated="2024-05-01" DateCreated="2022-11-29" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-08-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">26942287</ID>
          </Citation>
          <Comment>The c.3456_3457delAG variant, located in coding exon 18 of the POGZ gene, results from a deletion of two nucleotides at nucleotide positions 3456 to 3457, causing a translational frameshift with a predicted alternate stop codon (p.E1154Tfs*4). This alteration was detected as de novo occurrences in two individuals with intellectual disability and developmental delay (Stessman HAF et al. Am. J. Hum. Genet., 2016 Mar;98:541-552). This amino acid position is highly conserved in available vertebrate species. This alteration is expected to result in loss of function by premature protein truncation. As such, this alteration is interpreted as a likely pathogenic variant.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="POGZ" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015100.3:c.3456_3457delAG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0950123" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7823342" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2023-12-24">
        <ClinVarSubmissionID localKey="179609|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004183584" DateUpdated="2024-07-15" DateCreated="2023-12-24" Type="SCV" Version="6" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>POGZ: PS2, PVS1:Strong, PM2, PS4:Moderate</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="POGZ" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="1" alternateAllele="C" referenceAllele="CCT" start="151378053" stop="151378055" variantLength="3" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB14102099</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9874507" SubmissionDate="2024-07-18" DateLastUpdated="2024-07-23" DateCreated="2024-07-23">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_015100_3_POGZ_c_3456_3457delAG" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV005086001" DateUpdated="2024-07-23" DateCreated="2024-07-23" Type="SCV" Version="1" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with White-Sutton syndrome (MIM#616364). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0205 - Variant is predicted to result in a truncated protein (premature termination codon is NOT located at least 54 nucleotides upstream of the final exon-exon junction) with less than 1/3 of the protein sequence affected. (SP) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0701 - Other protein truncating variants comparable to the one identified in this case have very strong previous evidence for pathogenicity (DECIPHER). (SP) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. This variant has been reported multiple times as pathogenic, where a majority of individuals were de novo. A single case was reported to be maternally inherited, with limited clinical information provided for the mother (ClinVar, DECIPHER). (SP) 1206 - This variant has been shown to be paternally inherited (by trio analysis). (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="POGZ" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_23715</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015100.3:c.3456_3457delAG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="616364" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_45</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5043620" TraitType="Disease" MappingType="XRef" MappingValue="616364" MappingRef="OMIM">
        <MedGen CUI="C4225351" Name="Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7909097" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001263" MappingRef="HP">
        <MedGen CUI="C0557874" Name="Global developmental delay" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5030275" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002511" MappingRef="HP">
        <MedGen CUI="C0002395" Name="Alzheimer disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5464631" TraitType="Disease" MappingType="XRef" MappingValue="616364" MappingRef="OMIM">
        <MedGen CUI="C4225351" Name="Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="498945" TraitType="Disease" MappingType="Name" MappingValue="WHITE-SUTTON SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C4225351" Name="Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1857344" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5030275" TraitType="Disease" MappingType="XRef" MappingValue="616364" MappingRef="OMIM">
        <MedGen CUI="C4225351" Name="Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7909097" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000717" MappingRef="HP">
        <MedGen CUI="C0004352" Name="Autism" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5099976" TraitType="Disease" MappingType="XRef" MappingValue="C0950123" MappingRef="MedGen">
        <MedGen CUI="C0950123" Name="Inborn genetic diseases" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7576283" TraitType="Disease" MappingType="XRef" MappingValue="616364" MappingRef="OMIM">
        <MedGen CUI="C4225351" Name="Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7909097" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001344" MappingRef="HP">
        <MedGen CUI="C1854882" Name="Absent speech" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9874507" TraitType="Disease" MappingType="XRef" MappingValue="616364" MappingRef="OMIM">
        <MedGen CUI="C4225351" Name="Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2305913" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5014973" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0700092" MappingRef="MONDO">
        <MedGen CUI="C1535926" Name="Neurodevelopmental disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3877340" TraitType="Disease" MappingType="XRef" MappingValue="C4225351" MappingRef="MedGen">
        <MedGen CUI="C4225351" Name="Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3879258" TraitType="Disease" MappingType="XRef" MappingValue="616364" MappingRef="OMIM">
        <MedGen CUI="C4225351" Name="Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7909097" TraitType="Disease" MappingType="XRef" MappingValue="616364" MappingRef="OMIM">
        <MedGen CUI="C4225351" Name="Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7823342" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

